Summary : Glenmark Pharmaceuticals on Monday said its subsidiary has inked a pact to commercialise AstraZeneca’s asthma drug Pulmicort Respules in the…
pharma
-
-
Global MarketPharma Science & Research
Lilly, Roche Push Back Against CMS Draft Guidance on Aduhelm
by adminby adminSummary The U.S. Centers for Medicare & Medicaid Services (CMS) just completed the open comment period for their draft national coverage decision…
-
-
BiogenGlobal Market
Biogen Officially Weighs in On Medicare Draft Guidance for Aduhelm
by adminby adminSummary – In mid-January, the Centers for Medicare & Medicaid Services (CMS) issued a draft national coverage decision for Biogen’s Alzheimer’s drug…
-
Global MarketIndia
Glenmark Pharma inks exclusive licensing agreement with Lotus International
by adminby adminSummary : Under the agreement signed between Glenmark Specialty SA and the wholly-owned subsidiary of Lotus Pharmaceutical Co, Ltd (Lotus), Glenmark will…
-
India
CritiCare Hospitals acquires Kohinoor Hospital to address growing demand of quality healthcare
by adminby adminSummary With this addition, CritiCare Asia Multispecialty Hospitals will now have three facilities in Mumbai with a large pool of experienced medical…
-
Global MarketPharma Science & Research
First study to show waning effectiveness of 3rd dose of mRNA vaccines
by adminby adminSummary : A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity…
-
CompaniesEli LillyRegulatoryU.S FDA
Lilly’s bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
by adminby adminSummary : The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates…
-
Lupin Pharma
Lupin partners Medis for distribution of NaMuscla in Central, Eastern Europe
by adminby adminSummary : Drug firm Lupin on Wednesday said it has entered into a distribution pact with Slovenia-based Medis for its orphan drug…
-
Amgen Inc.Global Market
Amgen 2021 Revenue Propped up by COVID-19 Manufacturing Collab
by adminby adminSummary : Amgen has posted a 3% rise in total 2021 fourth-quarter revenues to $6.8 billion and a 2% increase in total revenue for the year…